Omega Healthcare Investors (NYSE:OHI) updated its fourth quarter 2019 earnings guidance on Monday. The company provided earnings per share guidance of $0.78-0.81 for the period. Omega Healthcare Investors also updated its FY 2019 guidance to $3.00-3.12 EPS.
Several brokerages recently issued reports on OHI. Zacks Investment Research raised Omega Healthcare Investors from a sell rating to a hold rating in a research note on Wednesday, October 31st. Stifel Nicolaus cut Omega Healthcare Investors from a buy rating to a hold rating and set a $39.00 price objective on the stock. in a research note on Thursday. Scotiabank initiated coverage on Omega Healthcare Investors in a research note on Thursday. They issued a sector perform rating and a $39.37 price objective on the stock. ValuEngine upgraded Omega Healthcare Investors from a hold rating to a buy rating in a report on Tuesday, November 20th. Finally, Bank of America restated a hold rating on shares of Omega Healthcare Investors in a report on Monday, November 19th. Eight analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Omega Healthcare Investors presently has an average rating of Hold and an average price target of $34.44.
Omega Healthcare Investors stock traded up $0.08 during mid-day trading on Monday, reaching $39.26. 1,549,449 shares of the company were exchanged, compared to its average volume of 1,657,602. The company has a quick ratio of 4.17, a current ratio of 4.17 and a debt-to-equity ratio of 1.21. The firm has a market cap of $7.86 billion, a P/E ratio of 11.90, a P/E/G ratio of 6.37 and a beta of 0.52. Omega Healthcare Investors has a 12-month low of $25.05 and a 12-month high of $40.30.
The business also recently announced a quarterly dividend, which will be paid on Friday, February 15th. Shareholders of record on Thursday, January 31st will be issued a dividend of $0.66 per share. The ex-dividend date is Wednesday, January 30th. This represents a $2.64 dividend on an annualized basis and a yield of 6.72%. Omega Healthcare Investors’s dividend payout ratio is currently 80.00%.
In related news, insider Michael Ritz sold 2,000 shares of the firm’s stock in a transaction on Monday, November 19th. The stock was sold at an average price of $35.50, for a total value of $71,000.00. Following the completion of the transaction, the insider now owns 8,076 shares in the company, valued at approximately $286,698. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Steven J. Insoft sold 50,000 shares of the firm’s stock in a transaction on Thursday, January 31st. The stock was sold at an average price of $40.00, for a total value of $2,000,000.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 86,000 shares of company stock valued at $3,321,750. 1.65% of the stock is owned by company insiders.
ILLEGAL ACTIVITY NOTICE: This piece was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright legislation. The original version of this piece can be accessed at https://www.americanbankingnews.com/2019/02/11/omega-healthcare-investors-ohi-updates-q4-2019-earnings-guidance.html.
Omega Healthcare Investors Company Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Read More: Why Dividend Stocks May Be Right for You
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.